Fundraising Fox
Lasarrus
3 known investors
Find your way into Lasarrus
Sign up to see every warm intro you have to Lasarrus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lasarrus team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
Investors · 3
Related companies · 1
Companies working in the same space as Lasarrus.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2021 | $256K |
| National Science Foundation | Phase ISTTR | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Lasarrus do?
- Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
- Who are Lasarrus's investors?
- Lasarrus's investors include Atlanta Technology Angels, Maryland TEDCO, TEDCO.